Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: OTC US
  • Sector: Health Care
  • Industry: Medical Equipment & Devices
  • Sub-Industry: Health Care Supplies

InVivo Therapeutics Holdings Corp

+ Add to Watchlist

NVIV:US

3.0800 USD 0.0600 1.99%

As of 10:05:00 ET on 03/03/2015.

Snapshot for InVivo Therapeutics Holdings Corp (NVIV)

Open: 3.0400 Day's Range: 3.0300 - 3.1200 Volume: 413,667
Previous Close: 3.0200 52wk Range: 0.4651 - 3.1200 1-Yr Rtn: +20.78%

Stock Chart for NVIV

No chart data available.
  • NVIV:US 3.0740
  • 1D
  • 1M
  • 1Y
3.0200
Interactive NVIV Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for NVIV

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -0.1573
Est. EPS (USD) (12/2014) -
Est. PEG Ratio -
Market Cap (M USD) 306.67
Shares Outstanding (M) 101.55
30 Day Average Volume 1,420,727
Price/Book (mrq) 21.2638
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 03/17/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for NVIV

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for NVIV

InVivo Therapeutics Holdings Corp., through its subsidiary, is a medical device company. The Company is focused on utilizing polymers as a platform technology to develop treatments to improve function in individuals paralyzed as a result of traumatic spinal cord injury.

Mark D PerrinChief Executive OfficerSteven McAllister "Steve"Chief Financial Officer
Lorianne K MasuokaChief Medical OfficerThomas R UlichChief Scientific Officer
More Company Profile & Key Executives for NVIV

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil